天弘国证生物医药ETF发起式联接A (011040.jj ) 生物医药 (半年) 天弘基金管理有限公司申 | 基金类型指数型基金(ETF,联接型)成立日期2021-01-27总资产规模 (2025-12-31) 基金净值0.4262元 (2026-02-13) 基金经理贺雨轩管理费用率0.50%管托费用率0.10% (2025-06-30) 持仓换手率19.13% (2025-06-30) 成立以来分红再投入年化收益率-15.55% (5646 / 5672) |
| 相关基金: | 主从基金: 天弘国证生物医药ETF发起式联接C目标基金: 天弘国证生物医药ETF |
| 备注 (1): | 双击编辑备注 |
天弘国证生物医药ETF发起式联接A(011040) - 历史月度涨跌幅
| 年 | 基金名称 | 1月 | 2月 | 3月 | 4月 | 5月 | 6月 | 7月 | 8月 | 9月 | 10月 | 11月 | 12月 | 年度涨跌幅 | 年度超额收益率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 天弘国证生物医药ETF发起式联接A | 2.64% | -1.23% | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.38% | 0.08% |
| 生物医药 | 2.64% | -1.30% | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.30% | ||
| 2025 | 天弘国证生物医药ETF发起式联接A | -3.93% | 4.15% | 0.48% | -5.97% | 6.40% | 1.50% | 14.92% | 2.45% | 2.10% | -4.40% | -6.53% | -3.31% | 6.03% | 0.81% |
| 生物医药 | -4.18% | 4.39% | 0.62% | -6.34% | 6.38% | 1.28% | 15.52% | 2.70% | 2.02% | -4.63% | -6.88% | -3.61% | 5.22% | ||
| 2024 | 天弘国证生物医药ETF发起式联接A | -21.95% | 13.08% | -5.92% | -1.57% | -4.77% | -6.18% | 3.00% | -7.44% | 26.55% | -5.75% | -0.02% | -5.89% | -21.87% | 2.80% |
| 生物医药 | -23.02% | 13.90% | -6.44% | -1.89% | -5.34% | -7.24% | 3.16% | -8.15% | 27.99% | -6.27% | -0.01% | -6.22% | -24.68% | ||
| 2023 | 天弘国证生物医药ETF发起式联接A | 6.49% | -4.59% | -7.77% | -3.05% | -6.37% | -5.98% | 5.42% | -4.48% | 2.66% | 3.54% | 1.42% | -6.52% | -18.85% | 2.29% |
| 生物医药 | 6.72% | -4.90% | -8.30% | -3.42% | -7.07% | -6.92% | 5.78% | -4.87% | 2.71% | 3.74% | 1.47% | -6.80% | -21.14% | ||
| 2022 | 天弘国证生物医药ETF发起式联接A | -15.13% | 4.07% | 2.27% | -12.57% | -1.73% | 12.90% | -9.67% | -3.37% | -11.59% | 2.23% | 6.47% | 0.29% | -26.19% | 2.37% |
| 生物医药 | -16.22% | 4.37% | 2.52% | -13.40% | -2.08% | 12.93% | -10.26% | -3.72% | -12.23% | 2.14% | 6.96% | 0.45% | -28.56% | ||
| 2021 | 天弘国证生物医药ETF发起式联接A | -- | -7.43% | -0.42% | 18.08% | 1.70% | -0.60% | -3.98% | -10.69% | 2.42% | -4.97% | 2.11% | -8.85% | -- | -- |
| 生物医药 | 4.79% | -4.71% | -1.07% | 18.76% | 0.70% | -1.03% | -4.77% | -11.53% | 2.41% | -5.30% | 2.21% | -9.28% | -11.42% | ||
| 2020 | 天弘国证生物医药ETF发起式联接A | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 生物医药 | 8.11% | 5.36% | 2.40% | 12.59% | 8.24% | 20.82% | 25.95% | -11.05% | -8.74% | 2.40% | -12.20% | 9.45% | 72.80% | ||
| 2019 | 天弘国证生物医药ETF发起式联接A | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 生物医药 | -5.67% | 23.58% | 14.97% | -4.61% | -4.51% | 5.35% | 1.65% | 8.37% | 1.99% | 6.33% | -4.71% | 5.06% | 53.80% | ||
| 2018 | 天弘国证生物医药ETF发起式联接A | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 生物医药 | -3.64% | -3.34% | 10.74% | 3.53% | 5.84% | -7.81% | -6.98% | -1.86% | 1.98% | -13.25% | 7.70% | -14.62% | -22.61% | ||
| 2017 | 天弘国证生物医药ETF发起式联接A | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 生物医药 | -4.34% | 4.29% | -1.04% | -0.50% | -3.35% | 4.20% | -6.82% | 4.59% | 4.47% | 5.61% | -0.88% | -0.73% | 4.67% | ||
| 2016 | 天弘国证生物医药ETF发起式联接A | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 生物医药 | -23.76% | -2.94% | 9.73% | -0.96% | -0.06% | 5.20% | 3.18% | 3.49% | -0.47% | -2.05% | 1.40% | -6.35% | -16.42% | ||
| 2015 | 天弘国证生物医药ETF发起式联接A | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 生物医药 | 0.08% | 5.99% | 23.29% | 13.67% | 27.65% | -10.65% | -3.90% | -14.62% | -0.43% | 9.33% | 0.60% | 5.07% | 60.10% |